Pennsylvania HB2734 mandates coverage for treatments to slow Alzheimer's disease and related dementias in health insurance policies.
Pennsylvania HB2734 amends the Insurance Company Law of 1921 to require insurers offering health insurance policies to cover medically necessary diagnostic testing and treatments for Alzheimer's disease and related dementias. This coverage must include FDA-approved medications prescribed by healthcare practitioners. The mandate excludes step therapy protocols and applies to all health insurance policies, excluding certain types like accident-only or Medicare supplement policies. The act takes effect 60 days after enactment.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.